Kenneth C. Frazier, chairman and chief executive officer of Merck, sat down with Tony Coles, M.D., chairman and chief executive officer of Yumanity Therapeutics and chairman of Cerevel Therapeutics, ...

Kenneth C. Frazier is exactly the type of exceptional ... As a CEO, he has directed Merck to increase its investment in bold, lifesaving treatments. As a leader, he has advised—and stood up ...

Merck & Co’s CEO Kenneth Frazier has said the pharma industry must take on the challenge of its poor public perception. In an interview with Yahoo Finance, Frazier defended the industry’s ...

Merck & Co's CEO has portrayed innovative pharma firms as the good guys of the drug industry ahead of an expected showdown over pricing in 2017 with Donald Trump. Kenneth Frazier was talking in a ...

Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...

Frazier took a risk by becoming the first of Trump’s advisers to speak out and step down, enabling others to follow suit. His success at Merck only bolsters his credibility: Since he took over ...